Case Report: Toxic epidermal necrolysis associated with sintilimab in a patient with relapsed thymic carcinoma

Immune checkpoint inhibitors (ICIs) such as anti-programmed death 1 (PD-1) receptor monoclonal antibody has been shown to be effective in patients with relapsed thymic carcinoma. However, immune-related adverse events (irAE) are increasingly recognized. There is a paucity of clinical data, especiall...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Huayu, Ma, Qing, Sun, Ying, Zhang, Kan, Xing, Yunli, Li, Hongwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813861/
https://www.ncbi.nlm.nih.gov/pubmed/36620577
http://dx.doi.org/10.3389/fonc.2022.1065137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813861/
https://www.ncbi.nlm.nih.gov/pubmed/36620577
http://dx.doi.org/10.3389/fonc.2022.1065137

Ejemplares similares